PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2022.01862022283425-472Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseasesHan Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kimhttp://e-cmh.org/upload/pdf/cmh-2022-0186.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0186, http://e-cmh.org/upload/pdf/cmh-2022-0186.pdf
Alimentary Pharmacology & Therapeutics10.1046/j.1365-2036.1999.00596.x1999138979-995Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases Trauner, Graziadeihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.1999.00596.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.1999.00596.x, http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.1999.00596.x/fullpdf
Journal of the Chinese Medical Association10.1016/j.jcma.2014.04.0102014777343-344Mechanisms of the beneficial effects of Ger-Gen-Chyn-Lian-Tang on acute and chronic liver injuryYing-Ying Yanghttps://api.elsevier.com/content/article/PII:S1726490114001051?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1726490114001051?httpAccept=text/plain, https://journals.lww.com/10.1016/j.jcma.2014.04.010
Phytotherapy Research10.1002/ptr.5667201630101559-1571Non-alcoholic Fatty Liver Disease: Beneficial Effects of FlavonoidsMasoumeh Akhlaghihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fptr.5667, https://onlinelibrary.wiley.com/doi/full/10.1002/ptr.5667
Drugs10.1007/s40265-016-0546-72016765533-549Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionDenise C. Hsu, Irini Seretihttp://link.springer.com/content/pdf/10.1007/s40265-016-0546-7.pdf, http://link.springer.com/article/10.1007/s40265-016-0546-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40265-016-0546-7, http://link.springer.com/content/pdf/10.1007/s40265-016-0546-7.pdf
Clinical Physiology and Functional Imaging10.1111/cpf.125262018392122-127Cardiometabolic effects of antidiabetic drugs in non‐alcoholic fatty liver diseaseIben Rix, Julie Steen Pedersen, Heidi Storgaard, Lise Lotte Gluudhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcpf.12526, https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpf.12526
Journal of Applied Toxicology10.1002/jat.1310200828293-103Beneficial drugs for liver diseasesPablo Muriel, Yadira Rivera-Espinozahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjat.1310, https://onlinelibrary.wiley.com/doi/full/10.1002/jat.1310
Mechanisms of Neuroinflammation10.5772/intechopen.689382017Neuroinflammatory Signals during Acute and Chronic Liver DiseasesMatthew McMillin, Sharon DeMorrowhttp://www.intechopen.com/download/pdf/55281
Hepatobiliary & Pancreatic Diseases International10.1016/s1499-3872(15)60355-12015142139-144Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver diseaseRui Guo, Emily C Liong, Kwok Fai So, Man-Lung Fung, George L Tipoehttps://api.elsevier.com/content/article/PII:S1499387215603551?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1499387215603551?httpAccept=text/plain
Journal of Chronic Diseases10.1016/0021-9681(72)90187-719722510-11653Dependence Liability of ‘Non-Narcotic’ DrugsJoseph H. Skomhttps://api.elsevier.com/content/article/PII:0021968172901877?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0021968172901877?httpAccept=text/plain